Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Arsenic Trioxide × Clear all

NCT00004149 2018-08-17

Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy

Phase 2 Completed

Prostatic Neoplasms